An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types [article]

Sunho Park, Seung-Jun Kim, Donghyeon Yu, Samuel Pena-Llopis, Jianjiong Gao, Jin Suk Park, Hao Tang, Beibei Chen, Jiwoong Kim, Jessie Norris, Xinlei Wang, Min Chen (+8 others)
2015 bioRxiv   pre-print
Identification of altered pathways that are clinically relevant across human cancers is a key challenge in cancer genomics. We developed a network-based algorithm to integrate somatic mutation data with gene networks and pathways, in order to identify pathways altered by somatic mutations across cancers. We applied our approach to The Cancer Genome Atlas (TCGA) dataset of somatic mutations in 4,790 cancer patients with 19 different types of malignancies. Our analysis identified
more » ... fic altered pathways enriched with known cancer-relevant genes and drug targets. Consensus clustering using gene expression datasets that included 4,870 patients from TCGA and multiple independent cohorts confirmed that the altered pathways could be used to stratify patients into subgroups with significantly different clinical outcomes. Of particular significance, certain patient subpopulations with poor prognosis were identified because they had specific altered pathways for which there are available targeted therapies. These findings could be used to tailor and intensify therapy in these patients, for whom current therapy is suboptimal.
doi:10.1101/017582 fatcat:6qknjho7srfyzmt5663tm4ru2y